06 June 2019

Director/PDMR Dealing

Collagen Solutions plc (AIM:COS), the developer and manufacturer of biomaterials and regenerative medicines for the enhancement and extension of human life, is pleased to announce that, further to its announcements on 20 May 2019 and 5 June 2019 in connection with the Strategic Investment, Placing and Open Offer, the following Directors/PDMRs have acquired Shares at the Offer Price in the following amounts.

Director/PDMR Position Existing
Ordinary
Shares held
Shares
subscribed
for at Offer
Price
Aggregate
price paid
for Shares
Number of
Ordinary
Shares held
following
Admission
           
Malcolm Gillies Non-Executive Director 4,153,000 847,000 £42,350 5,000,000
Hilary Spence Chief Financial Officer 250,817 300,000 £15,000 550,817
Tom Hyland Chief Operating Officer 273,847 200,000 £10,000 473,847
Gillian Black Company Secretary 857,143 150,000 £7,500 1,007,143

Unless otherwise defined, capitalised terms shall have the same meaning as defined in the circular posted to Shareholders on 20 May 2019, which is available to view on the Company's website at www.collagensolutions.com

The Company makes the following disclosures in accordance with article 19(3) of the Market Abuse Regulations

1 Details of the person discharging managerial responsibilities / person closely associated
a) Name 1. Malcolm Gillies

2. Hilary Spence

3. Tom Hyland

4. Gillian Black
2 Reason for the notification
a) Position/status 1. Non-Executive Director

2. Chief Financial Officer

3. Chief Operating Officer

4. Company Secretary
b) Initial notification /Amendment Initial
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Collagen Solutions plc
b) LEI 213800IFY1CVGRGETL95
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Identification code New ordinary shares of 1p each ISIN: GB00B94T6Y14
b) Nature of the transaction Acquisition of new ordinary shares pursuant to placing, open offer and subscription
c) Price(s) and volume(s)
Price(s) Volume(s)
1. 5p per share 847,000
2. 5p per share 300,000
3. 5p per share 200,000
4. 5p per share 150,000
d) Aggregated information
- Aggregated volume
- Price
N/A
- single transactions
e) Date of the transaction 6 June 2019
f) Place of the transaction London Stock Exchange

 

Enquiries:

Collagen Solutions Plc Contact via Walbrook
Jamal Rushdy, CEO  
Hilary Spence, CFO  
   
Cenkos Securities Plc (Nominated Adviser and Broker) Tel: 0207 397 8900
Giles Balleny / Stephen Keys  
   
Walbrook PR Ltd Tel: 020 7933 8780 or collagen@walbrookpr.com
Anna Dunphy Mob: 07876 741 001